Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra for cardioprotection in pediatric AML during chemotherapy
ChiCTR2500102980Phase 2Recruiting
- Sponsor
- Shanghai Children's Medical Center
- Start
- Jul 2025
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of anakinra in acute myeloid leukemia (AML) (3 arms), sponsored by Shanghai Children's Medical Center. Primary endpoints: Phase II occurrence of cancer therapy-related cardiac dysfunction, Phase I physical examination, vital signs, laboratory tests, and ECG changes and 2 more. Started Jul 2025; status: recruiting.
02
Drugs
anakinra
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on ChiCTR2500102980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102980.